Literature DB >> 2947674

Fluorodeoxyuridine synchronization of hemopoietic colonies.

C Fraser, C J Eaves, D K Kalousek.   

Abstract

A method that allows the routine cytogenetic analysis of colonies growing in semisolid medium and containing as few as 50 cells is described. This method is based on the sequential addition of fluorodeoxyuridine and then thymidine to achieve higher mitotic yields by the synchronization of colony cells. In this study the schedule outlined was specifically optimized for application to small granulopoietic colonies from patients with Philadelphia chromosome (Ph)-positive chronic myeloid leukemia. In addition to increasing the spectrum of colony sizes yielding analyzable metaphases, this method significantly improved the general quality of the chromosome preparations obtained. Minor changes should enable this method to be applied to the analysis of colonies derived from a variety of other normal or malignant clonogenic cell types.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2947674     DOI: 10.1016/0165-4608(87)90077-x

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

1.  Deletion of chromosome 21 and normal intelligence: molecular definition of the lesion.

Authors:  J R Korenberg; D K Kalousek; G Anneren; S M Pulst; J G Hall; C J Epstein; D R Cox
Journal:  Hum Genet       Date:  1991-06       Impact factor: 4.132

2.  Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level.

Authors:  C Udomsakdi; C J Eaves; B Swolin; D S Reid; M J Barnett; A C Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

3.  Ex vivo expansion of normal and chronic myeloid leukemic stem cells without functional alteration using a NUP98HOXA10homeodomain fusion gene.

Authors:  I Sloma; S Imren; P A Beer; Y Zhao; V Lecault; D Leung; K Raghuram; C Brimacombe; K Lambie; J Piret; C Hansen; R K Humphries; C J Eaves
Journal:  Leukemia       Date:  2012-07-16       Impact factor: 11.528

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.